Wearables & Devices

SoundHealth Launches Android App for Its FDA-Approved SONU Band

SoundHealth Launches Android App for Its FDA-Approved SONU Band

The first-ever medical-grade Android app that uses a selfie to generate CT-accurate 3D data, the app powers AI-driven, drug-free treatment of rhinitis through the wearable SONU Band

SoundHealth, the medical technology company behind the SONU Band, has launched the first-ever medical-grade Android app capable of transforming a selfie into CT-accurate skeletal data for the treatment of rhinitis. The SONU Band is the world’s first FDA De Novo authorized, AI-enabled wearable medical device that uses sound-based therapy to relieve moderate to severe nasal congestion and allergy symptoms at home and without the need for drugs or sprays.

Built to work seamlessly with the band, the app leverages proprietary AI to analyze 3D facial scans in conjunction with symptom data and CT imaging to deliver precise, therapeutic-grade treatments for sinus and allergy-related conditions.

“We are thrilled to bring the SONU Band to Android users now,” said Dr. Paramesh Gopi, founder and CEO of SoundHealth. “Our Android app is a first of its kind, and this launch expands access to drug-free relief to millions of people suffering from allergies and sinus issues.”

The SONU app scans the patient’s face using a smartphone and creates a digital map of their sinuses, calculating their optimal resonant frequencies. Following the initial one-time scan, the patient simply places the SONU Band around their head, turns it on and the band delivers frequencies tailored to the patient.

The band opens airways naturally to reduce congestion and promote easy breathing, without drugs or steroids. Providing relief in just 15 minutes, SONU is recommended by over 1,000 doctors and dentists across the country.

SONU is the only FDA-approved device equivalent to or better than the leading nasal steroid spray, calming down symptoms of allergies, inflammation and congestion. It uses acoustic vibrational energy to provide personalized relief, reducing swelling, opening nasal passages and draining healthy mucus.

Over 80 percent of SONU patients report improvement in their nasal symptoms, representing a new category of safe and rapid relief therapies for nasal congestion. The SONU Band also recently received FDA approval for pediatric use for children over 12 years of age, giving families a safe alternative to pharmaceuticals.

SONU is convenient, user-friendly and pleasant to use for patients. For more information, please visit https://soundhealth.life/.

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

Business Wire

Business Wire is a trusted source for news organizations, journalists, investment professionals and regulatory authorities, delivering news directly into editorial systems and leading online news sources via its multi-patented NX Network. Business Wire has 18 newsrooms worldwide to meet the needs of communications professionals and news media.

Related posts

Mobile Device Re-commerce Leader ecoATM Gazelle Raises $75M

PR Newswire

HeartBeam announced two new appointments to Senior Management Team

Business Wire

Global call for entries announced for 2022 Garmin Health Awards

Business Wire